International Conference on

Structural Biology and Drug Design (ICSBDD-27)

Conference Date

25th Mar - 26th Mar 2027

Conference Venue

Surabaya, Indonesia

Conference Mode

Hybrid Conference
Proudly organized by:- Science Leagues

"Join global experts in Structural Biology and Drug Design"

Registration Options →

View all registration categories and choose the best fit.

Conference Programme

Tentative Conference Agenda

Explore the proposed two-day programme developed around the conference Session Tracks and aligned United Nations Sustainable Development Goals.

Conference Format Hybrid Conference In-person and virtual participation
Programme 2 Days 25–26 March 2027
Academic Scope 11 Tracks Conference Session Tracks
Research Scope 20 Areas Call for Papers themes
SDG Alignment 2 SDGs SDGs 3 and 9
Tentative Agenda & Timings

Session timings, sequence, track grouping and allocations are tentative and subject to change. Final timings will be confirmed closer to the conference. All timings follow the local time of the conference location.

Day 01

Opening, Keynote & Technical Sessions

25 MAR 2027 HYBRID
  1. 09:00 AM 09:30 AM

    Registration, Welcome Kit Collection & Virtual Check-in

    Participant arrival, credential verification and virtual lobby access.

    HYBRID
  2. 09:30 AM 09:45 AM

    Networking Tea & Digital Welcome

    Informal networking for on-site and virtual participants.

    HYBRID
  3. 09:45 AM 10:30 AM

    Welcome Address, Opening Plenary & Keynote Presentation I

    Opening of the conference and introduction to its research focus.

    PLENARY
  4. 10:30 AM 12:30 PM

    Concurrent Technical Session I

    3 TRACKS
    Track 01
    Advancements in Protein Crystallography
    39
    Track Overview

    This track focuses on the latest methodologies and technologies in protein crystallography, emphasizing their applications in drug design. Participants will explore case studies that highlight the impact of high-resolution structures on understanding protein function.

    Track 02
    Molecular Modeling and Simulation Techniques
    39
    Track Overview

    This session will delve into cutting-edge molecular modeling and simulation approaches used to predict protein-ligand interactions. Discussions will include advancements in computational techniques that enhance the accuracy of molecular dynamics simulations.

    Track 03
    Enzyme Structure and Function Relationships
    39
    Track Overview

    This track will examine the intricate relationships between enzyme structures and their catalytic functions. Researchers will present findings that elucidate how structural variations influence enzyme activity and specificity.

  5. 12:30 PM 01:30 PM

    Lunch & Networking Break

    Refreshment interval and networking opportunity.

    BREAK
  6. 01:30 PM 03:30 PM

    Concurrent Technical Session II

    3 TRACKS
    Track 04
    Computational Docking Strategies
    39
    Track Overview

    This session will cover innovative computational docking strategies that facilitate the identification of potential drug candidates. Emphasis will be placed on the integration of docking algorithms with experimental data to enhance predictive power.

    Track 05
    Structural Analysis of Macromolecular Complexes
    39
    Track Overview

    This track focuses on the structural analysis of macromolecular complexes, including protein-protein and protein-nucleic acid interactions. Participants will discuss techniques such as cryo-electron microscopy and X-ray crystallography that provide insights into complex formation.

    Track 06
    NMR Spectroscopy in Structural Biology
    39
    Track Overview

    This session will highlight the role of NMR spectroscopy in elucidating the structures of biomolecules in solution. Researchers will present novel applications of NMR in studying protein dynamics and conformational changes.

  7. 03:30 PM 04:00 PM

    Interactive Q&A, Day 1 Summary & Group Photo

    Closing interaction and key takeaways from the first day.

    CLOSING
Day 02

Keynote, Technical Sessions & Awards

26 MAR 2027 HYBRID
  1. 09:00 AM 09:15 AM

    Participant Check-in & Day 2 Welcome

    On-site attendance confirmation and virtual lobby access.

    HYBRID
  2. 09:15 AM 10:00 AM

    Keynote Presentation II

    Expert address on the future of the conference research domain.

    PLENARY
  3. 10:00 AM 12:00 PM

    Concurrent Technical Session III

    3 TRACKS
    Track 07
    Binding Site Analysis and Drug Design
    39
    Track Overview

    This track will explore methodologies for binding site analysis and their implications for rational drug design. Attendees will learn about computational tools that assist in identifying and characterizing druggable sites on target proteins.

    Track 08
    Protein Engineering for Therapeutic Applications
    39
    Track Overview

    This session will focus on the engineering of proteins for therapeutic purposes, including the design of enzyme inhibitors and biologics. Discussions will cover strategies for optimizing protein stability and activity.

    Track 09
    Medicinal Chemistry and Structural Insights
    39
    Track Overview

    This track will examine the intersection of medicinal chemistry and structural biology, emphasizing how structural insights inform the design of novel therapeutics. Participants will share case studies that illustrate successful collaborations between chemists and structural biologists.

  4. 12:00 PM 01:00 PM

    Lunch & Networking Break

    Refreshment interval and professional networking.

    BREAK
  5. 01:00 PM 03:00 PM

    Concurrent Technical Session IV

    2 TRACKS
    Track 10
    Rational Drug Design: Strategies and Successes
    39
    Track Overview

    This session will present various strategies employed in rational drug design, showcasing successful case studies that led to the development of new therapeutics. Emphasis will be placed on the integration of structural data into the drug discovery process.

    Track 11
    Protein-Ligand Interactions: Mechanisms and Applications
    39
    Track Overview

    This track will investigate the mechanisms underlying protein-ligand interactions and their relevance to drug efficacy. Participants will discuss experimental and computational approaches to studying these interactions in detail.

  6. 03:00 PM 03:30 PM

    Publications, Best Paper & Best Presentation Awards

    Publication guidance and recognition of outstanding research contributions.

    AWARDS
  7. 03:30 PM 04:00 PM

    Valedictory Session, Closing Remarks & Group Photo

    Conference summary, acknowledgements and formal conclusion.

    CLOSING
Aligned SDGs
3 Good Health and Well-being 9 Industry, Innovation and Infrastructure

Be Part of ICSBDD-27

Submit your research or complete your conference registration.